High-Dose Vitamin D Cuts Acute Respiratory Infection in Elderly

Share this content:
High-Dose Vitamin D Cuts Acute Respiratory Infection in Elderly
High-Dose Vitamin D Cuts Acute Respiratory Infection in Elderly

TUESDAY, Nov. 22, 2016 (HealthDay News) -- For long-term care facility residents, high-dose vitamin D3 supplementation is associated with reduced incidence of acute respiratory infection (ARI) but increased incidence of falls, according to a study published online Nov. 16 in the Journal of the American Geriatrics Society.

Adit A. Ginde, M.D., M.P.H., from the University of Colorado in Aurora, and colleagues conducted a randomized controlled trial among 107 long-term care residents aged 60 years and older. Participants were randomized to either a high-dose group that received monthly supplement of 100,000 IU vitamin D3 (55 participants) or a standard-dose group that received a monthly placebo or monthly supplement of 12,000 IU vitamin D3 for those taking 400 to 1,000 IU or <400 IU/day, respectively, as part of usual care (52 participants).

The researchers found that the high-dose and standard-dose groups had 0.67 and 1.11 ARIs per person-year (incidence rate ratio, 0.60; P = 0.02). The high-dose group had more falls (1.47 versus 0.63 per person-year; incidence rate ratio, 2.33; P < 0.001). Fractures were uncommon in both groups (0.10 versus 0.19 per person-year in the high-dose and standard-dose groups, respectively; P = 0.31). Neither group experienced hypercalcemia or kidney stones.

"Monthly high-dose vitamin D3 supplementation reduced the incidence of ARI in older long-term care residents but was associated with a higher rate of falls without an increase in fractures," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »